Patents by Inventor Andrew M. Yaksic

Andrew M. Yaksic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091253
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Application
    Filed: November 28, 2023
    Publication date: March 21, 2024
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Publication number: 20240009161
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Application
    Filed: October 21, 2021
    Publication date: January 11, 2024
    Applicant: Tygrus, LLC
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Patent number: 11826382
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: November 28, 2023
    Assignee: Tygrus, LLC
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Publication number: 20230218667
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Application
    Filed: March 16, 2023
    Publication date: July 13, 2023
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Patent number: 11642372
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: May 9, 2023
    Assignee: Tygrus, LLC
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Publication number: 20220133786
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Application
    Filed: December 10, 2021
    Publication date: May 5, 2022
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Publication number: 20220133785
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Application
    Filed: December 10, 2021
    Publication date: May 5, 2022
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Publication number: 20220096536
    Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Inventors: Paul Bundschuh, Lawrence Carlson, Shawn Dolan, Andrew M. Yaksic
  • Publication number: 20210338711
    Abstract: A therapeutic material active against SARS-COV 2 and other microbial pathogens and method of administering the same.
    Type: Application
    Filed: May 3, 2021
    Publication date: November 4, 2021
    Inventors: Lawrence Carlson, Anthony Atala, Patrick A. Scalera, Andrew M. Yaksic
  • Publication number: 20200290034
    Abstract: A method for regeneration of ion exchange material employed in a water softening or conditioning system. The method includes the step of contacting the ion exchange material with an aqueous process fluid to yield a regenerated ion exchange material. At least one target material associated with the resin is removed. The target material includes at least one of the following: metal ions such as those that have been extracted from a source of hard water, ionically soluble organic compounds, active water borne pathogens.
    Type: Application
    Filed: March 13, 2020
    Publication date: September 17, 2020
    Applicant: Tygrus, LLC
    Inventors: Lawrence Carlson, Andrew M. Yaksic
  • Publication number: 20200290895
    Abstract: A method for regeneration of an ion exchange material employed in a water softening or conditioning system that includes the step of contacting the ion exchange material with an aqueous process fluid to yield a regenerated ion exchange material, wherein the ion exchange material has at least one target material associated therewith. The target material includes at least one of the following: metal ions such as those that have been extracted from a source of hard water, ionically soluble organic compounds, active water borne pathogens.
    Type: Application
    Filed: March 13, 2020
    Publication date: September 17, 2020
    Applicant: Tygrus, LLC
    Inventors: Steven Mosher, Lawrence Carlson, Andrew M. Yaksic